The benefits beyond weight loss that apply to dual and triple agonists include improved sleep quality, reduced inflammation, better cardiovascular function, and enhanced insulin sensitivity
South Africas health regulator is reviewing 12 applications for generic versions of semaglutide, the ingredient in Ozempic and Wegovy
A valuable tool used to assess eligibility for weight management therapies, including GLP-1 receptor agonists, is Body Mass Index (BMI)
Without verification, users cannot know if they are receiving the correct peptide, proper purity, or even anything active at all
Research use only For qualified researchers
The tirzepatide weight loss results research breaks down what the clinical data actually shows